Compounds > pyrimidine
Page last updated: 2024-08-21

pyrimidine and Prostatic Neoplasms

pyrimidine has been researched along with Prostatic Neoplasms in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Mathur, D; Mulholland, D; Ozturk, S; Parsons, R; Zhou, RW1
Arnold, RS; Clendinen, CS; Edison, AS; Fernández, FM; Gaul, DA; Monge, ME; Petros, JA1
Johnson, J; Li, Z; Tandon, M; Wang, QJ; Wipf, P; Xu, S1
Cabon, F; Delongchamps, NB; Firlej, V; Fritsch, L; Gallou-Kabani, C; Gilbert, C; Guarmit, B; Mathieu, JR; Morin, A; Vieillefond, A1

Other Studies

4 other study(ies) available for pyrimidine and Prostatic Neoplasms

ArticleYear
Leflunomide triggers synthetic lethality in PTEN-deficient prostate cancer.
    Prostate cancer and prostatic diseases, 2020, Volume: 23, Issue:4

    Topics: Animals; Cell Line; Cell Line, Tumor; Humans; Immunosuppressive Agents; Leflunomide; Male; Mice; Mice, Nude; Prostatic Neoplasms; PTEN Phosphohydrolase; Pyrimidines; Synthetic Lethal Mutations; Xenograft Model Antitumor Assays

2020
Preoperative Metabolic Signatures of Prostate Cancer Recurrence Following Radical Prostatectomy.
    Journal of proteome research, 2019, 03-01, Volume: 18, Issue:3

    Topics: Amino Acids; Big Data; Chromatography, Liquid; Citric Acid Cycle; Glucose; Humans; Lactic Acid; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Metabolomics; Middle Aged; Neoplasm Recurrence, Local; Preoperative Period; Prostatectomy; Prostatic Neoplasms; Purines; Pyrimidines; Tryptophan

2019
New pyrazolopyrimidine inhibitors of protein kinase d as potent anticancer agents for prostate cancer cells.
    PloS one, 2013, Volume: 8, Issue:9

    Topics: Antineoplastic Agents; Cell Cycle Checkpoints; Cell Division; Cell Line, Tumor; Cell Movement; Cell Proliferation; G2 Phase; Humans; Male; Prostatic Neoplasms; Protein Kinase C; Protein Kinase Inhibitors; Pyrimidines; Structure-Activity Relationship

2013
Identification of CAD as an androgen receptor interactant and an early marker of prostate tumor recurrence.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2012, Volume: 26, Issue:1

    Topics: Androgens; Animals; Aspartate Carbamoyltransferase; Biomarkers, Tumor; Carbamoyl-Phosphate Synthase (Glutamine-Hydrolyzing); Cell Line, Tumor; Cell Nucleus; Cytosol; Dihydroorotase; Humans; Male; Mice; Neoplasm Recurrence, Local; Neoplasm Transplantation; Predictive Value of Tests; Prostatic Neoplasms; Pyrimidines; Receptors, Androgen; RNA, Small Interfering; Transcription, Genetic; Transplantation, Heterologous

2012